These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19789496)

  • 1. Is oestrogen neuroprotective?
    Agius M; Hockings H; Wilson C; Lane D
    Psychiatr Danub; 2009 Sep; 21 Suppl 1():120-7. PubMed ID: 19789496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
    Lieberman JA; Malaspina D; Jarskog LF
    CNS Spectr; 2006 Apr; 11(4):suppl 1-13; quiz suppl 14-5. PubMed ID: 16641837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a better identification and treatment of schizophrenia prodrome.
    Bota RG; Sagduyu K; Filin EE; Bota DA; Munro S
    Bull Menninger Clin; 2008; 72(3):210-27. PubMed ID: 18990056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethics of the early intervention in the treatment of schizophrenia.
    Filaković P; Degmecić D; Koić E; Benić D
    Psychiatr Danub; 2007 Sep; 19(3):209-15. PubMed ID: 17914322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dilemma of early drug intervention in prepsychotic illnesses of adolescence].
    Branik E; Meng H
    Prax Kinderpsychol Kinderpsychiatr; 2003 Dec; 52(10):751-65. PubMed ID: 14699785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brain imaging and transition to psychosis].
    McGuire P
    Encephale; 2010 Mar; 36 Suppl 3():S66-70. PubMed ID: 21095395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state.
    Hurlemann R; Jessen F; Wagner M; Frommann I; Ruhrmann S; Brockhaus A; Picker H; Scheef L; Block W; Schild HH; Moller-Hartmann W; Krug B; Falkai P; Klosterkotter J; Maier W
    Psychol Med; 2008 Jun; 38(6):843-51. PubMed ID: 18387213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
    Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormones and schizophrenia.
    Kulkarni J; Hayes E; Gavrilidis E
    Curr Opin Psychiatry; 2012 Mar; 25(2):89-95. PubMed ID: 22249082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase.
    Weiser M
    Am J Psychiatry; 2011 Aug; 168(8):761-3. PubMed ID: 21813489
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.
    Mittal VA; Neumann C; Saczawa M; Walker EF
    Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervention in the at-risk state to prevent transition to psychosis.
    Ruhrmann S; Schultze-Lutter F; Klosterkötter J
    Curr Opin Psychiatry; 2009 Mar; 22(2):177-83. PubMed ID: 19553872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection and intervention of psychosis. A review.
    Salokangas RK; McGlashan TH
    Nord J Psychiatry; 2008; 62(2):92-105. PubMed ID: 18569772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early intervention in increased risk for schizophrenic illnesses. Multimodal psychotherapy--antipsychotic drugs only in treatment failure].
    Wieneke A; Bechdolf A; Schultze-Lutter F
    MMW Fortschr Med; 2000 Mar; 142(10):30-2. PubMed ID: 10748600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early detection and intervention in first episode psychosis].
    Bechdolf A
    MMW Fortschr Med; 2009 May; 151(22):45-7. PubMed ID: 19526969
    [No Abstract]   [Full Text] [Related]  

  • 19. Pre-attentive auditory processing in ultra-high-risk for schizophrenia with magnetoencephalography.
    Shin KS; Kim JS; Kang DH; Koh Y; Choi JS; O'Donnell BF; Chung CK; Kwon JS
    Biol Psychiatry; 2009 Jun; 65(12):1071-8. PubMed ID: 19200950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do estrogens have an antipsychotic action?].
    Riecher-Rössler A; Häfner H; Stumbaum M; Schmidt R
    Fortschr Neurol Psychiatr; 1994 Jan; 62(1):22-8. PubMed ID: 8144127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.